OA
ANGO icon

Operose Advisors’s AngioDynamics ANGO Stock Holding History

Operose Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-600
Closed -$4.39K – 605
2023
Q3 		$4.39K Buy
+600
New +$4.99K ﹤0.01% 668
2022
Q2 		– Sell
-397
Closed -$9K – 302
2022
Q1 		$9K Hold
397
– – 0.01% 266
2021
Q4 		$11K Buy
+397
New +$11K 0.01% 249

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Operose Advisors's ANGO Position: Q4 2023 in Review

Operose Advisors sold out of AngioDynamics (ANGO) in Q4 2023, closing a stake of 600 shares — an estimated $4.39K sold.

Operose Advisors first reported a position in ANGO in Q4 2021 and held it in 3 quarters. The position peaked at $11K in Q4 2021. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.

  • Operose Advisors reported no remaining AngioDynamics position as of Q4 2023 after selling out during the quarter.
  • Operose Advisors sold 600 AngioDynamics shares in Q4 2023, an estimated $4.39K.
  • Operose Advisors first reported a position in AngioDynamics in Q4 2021 and held it in 3 quarters.
  • Operose Advisors's AngioDynamics position peaked at $11K in Q4 2021.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.